Mr. Corbin joins the company from Luitpold Pharmaceuticals, Inc., where managed technical quality operations. Previously, he held technical leadership positions with Genzyme, Lonza Biologics, and Glaxo/Wellcome. Mr. Corbin is an accredited ASQ Quality Auditor and ISO 13485 Certified Internal Auditor.
“With Scott’s depth of experience, including the manufacture and validation of biologics, medical devices and pharmaceutical products, we anticipate that he will deliver tangible, long-term value for our clients,” said Dave Goswami, PE, chief executive officer and chairman, IPS. “He has demonstrated leadership in delivering innovative and cost effective solutions in validation and quality assurance along with cutting-edge manufacturing and operations expertise. With the addition of Scott, IPS is well-positioned to help achieve strategic and business goals for companies located in New England.”